PowerShares Dynamic Biotech & Genome | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (43)

View All

Latest Posts

About This Stock More About This Stock
A Comprehensive Guide To Genomic ETFs
Article By: Zacks Investment Research
Sunday, July 11, 2021 1:59 PM EDT
Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon make genomics the next big thing in the space.
In this article: GNOM, PBE, ARKG, IDNA, NTLA, CRSP Also: BEAM, EDIT
Read
5 Top ETFs With Exposure To Biogen
Article By: Benzinga
Monday, June 7, 2021 4:26 PM EDT
Here is a look at five ETFs with large exposure to Biogen shares.
In this article: IBB, BBH, FBT, PBE, PKW Also: BIIB, GILD, ORCL, MRNA, BNTX
Read
ETFs In Focus On Bayer's Bet On Gene Therapy
Article By: Sweta Killa
Thursday, October 29, 2020 11:58 PM EDT
Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.
In this article: GNOM, PBE, ARKG, IDNA
Read
Profit From The Genomics Market Momentum With These ETFs
Article By: Zacks Investment Research
Saturday, May 23, 2020 7:04 PM EDT
It appears that growing demand for personalized medicine, solid investments and higher R&D activities can make genomics the next big thing in the investing space. We highlight a host of ETFs that investors can keep tabs on.
In this article: GSK, GNOM, PBE, ARKG, IDNA
Read
The Landscape Of Biotech ETFs
Article By: Nancy Zhang
Tuesday, January 8, 2019 2:17 AM EDT
The challenge is to create a quality biotech index with a rule-based system, so the picking and re-balancing are handy and quick.
In this article: IBB, PBE, BBC, CNCR
Read
All Posts

Latest Tweets for $PBE

No tweets yet!

PARTNER HEADLINES